Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports .
AI responses may include mistakes. For financial advice, consult a professional. Learn more
Your (e.g., comfortable with high volatility)? Your investment timeframe ?
🍪 Ready to add some flavor to your browsing? Our site uses cookies for a sprinkle of personalization, ads with a dash of fun, and to keep our traffic flowing smoothly. By clicking "Accept All", you consent to our use of cookies.